![1]()
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
![1]()
News
Beware nonopiate meds with high street value
April 25, 2018
NEW ORLEANS – Use these safeguards when prescribing gabapentin and other high-abuse-potential drugs.
![1]()
News
Nonopioids as effective as opioids in reducing acute pain in the ED
April 23, 2018
Clinical question: What is the most effective analgesic combination, opioid vs. nonopioid, for treating acute extremity pain in the emergency department?
![1]()
News
Common infections are potent risk factor for MI, stroke
April 13, 2018
ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.
![1]()
News
New guidance for inpatient opioid prescribing
April 9, 2018
The SHM consensus statement advocates the lowest effective dose for the shortest duration possible.
![1]()
News
Journal of Hospital Medicine releases consensus statement on inpatient opioid prescribing
April 8, 2018
Recommendations on how to improve the safety of opioid prescribing both during hospitalization and at discharge.
![1]()
News
CMS finalizes measures to help combat opioid crisis
April 5, 2018
Federal agencies and leaders are taking a multipronged approach to the opioid crisis.
![1]()
News
Synthetic opioids drive increase in overdose deaths
March 29, 2018
Illegally manufactured fentanyl is now being combined with other drugs.
![1]()
News
New consensus on inpatient opioid use
March 29, 2018
This session will focus on new recommendations to improve opioid prescribing for acute, noncancer pain in hospitalized adults.
![1]()
News
FDA advisors recommend lofexidine for opioid withdrawal
March 27, 2018
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
